Takeda Pharmaceutical Company Limited Revenue From Interest
Takeda Pharmaceutical Company Limited (TKPHF) reported Revenue From Interest of JPY 19.64 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Income Statement › Other Income
ifrs-full:RevenueFromInterest · last filed 2025-06-25
| Period end | Revenue From Interest 12 month |
|---|---|
| 2025-03-31 | 19.64B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 11.29B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 5.51B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 4.59B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 1.78B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 11.20B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 6.62B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 3.28B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 2.02B JPY 20-F · filed 2019-06-27 |